Lupus Clinical Trials in New York

Showing 161-180 of 279 trials

LAGB as a Treatment for Morbid Obesity in Adolescents

NCT01045499

Laparoscopic adjustable gastric banding (LAGB) has been used worldwide to help selected morbidly obese adults to lose weight. The FDA has approved LAGB only for patients 18 years or older. Our hypothesis that LAGB can be used to assist selected adolescents between 14 and 17 years lose weight and that the procedure can be performed safely in this age group. We are also evaluating the effects of weight loss after LAGB on known comorbid conditions such as sleep apnea syndrome and insulin resistance, and also on psychological health.

Morbid ObesityObstructive Sleep Apnea SyndromeMetabolic Syndrome+2 more

Jeffrey L Zitsman, MD137 participantsStarted Sep 2005

New York, New York, United States

COMPLETEDPhase 2< 1 mile

A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus

NCT02349061

The purpose of this study is to evaluate the efficacy of ustekinumab as measured by a reduction in disease activity for subjects with active Active Systemic Lupus Erythematosus (SLE - chronic disorder of connective tissue in which there can be skin rash, arthritis, kidney problems, and anemia, among other problems).

Lupus Erythematosus, Systemic

Janssen Research & Development, LLC102 participantsStarted Oct 2015

Huntsville, Alabama, United States • Beverly Hills, California, United States • Tampa, Florida, United States +40 more locations

LAGB as a Treatment for Morbid Obesity in Adolescents

A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus

Lupus Trials in Other Cities

Nelfinavir in Systemic Lupus Erythematosus

Ketamine and Propofol Combination Versus Propofol for Upper Gastrointestinal Endoscopy

Use of Temperature Controlling Mattress Pad for Sleep Improvement

Research Exploring Sleep Education & Technology

Social Circumstances, Parenting Techniques, and Infant Development

FLARE Lupus Research Study Systemic Lupus Erythematosus

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN)

Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)

Clinical Validation of New Commercial Sleep Monitoring Devices

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients

SNORE (Smartphone Analyses of Nocturnal Obstruction by Respiratory Evaluation) SOUNDS

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

Other Conditions in New York